Evaluating blood sugar response to no-added-sugar ice cream in people with type 2 diabetes
Postprandial Glycaemic Changes When Patients With Type 2 Diabetes Consume the New KDD Products
This study is testing whether eating no-added-sugar ice cream affects blood sugar levels differently than regular ice cream in people with type 2 diabetes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 12 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Dasman Diabetes Institute Academic / other |
| Locations | 1 site (Kuwait City, Dasman) |
| Trial ID | NCT06135935 on ClinicalTrials.gov |
What this trial studies
This study investigates the postprandial glycemic response of individuals with type 2 diabetes after consuming no-added-sugar ice cream compared to conventional ice cream. The research is part of a broader initiative to develop healthier food products that can improve metabolic health. Participants will be monitored for their blood sugar levels after consumption to assess the impact of these new ice cream products. The study aims to provide evidence-based insights into how dietary changes can benefit metabolic health in the Kuwaiti population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with type 2 diabetes and with an HbA1c level between 6.5% and 8.5%.
Not a fit: Patients who are lactose intolerant or do not enjoy chocolate ice cream may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to healthier dessert options that help manage blood sugar levels in patients with type 2 diabetes.
How similar studies have performed: While there is ongoing research into low-sugar products, this specific approach using no-added-sugar ice cream is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Type 2 diabetes 2. Aged over 18 years 3. HbA1c 6.5-8.5% (48-69 mmol/L) Exclusion Criteria: 1. Lactose intolerant 2. Not liking chocolate ice cream
Where this trial is running
Kuwait City, Dasman
- Ebaa Al Ozairi — Kuwait City, Dasman, Kuwait (Recruiting)
Study contacts
- Principal investigator: Ebaa Al Ozairi, MD — Dasman Diabetes Institute
- Study coordinator: Ebaa Al Ozairi
- Email: ebaa.alozairi@dasmaninstitute.org
- Phone: 22242999
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.